Treatment
-
From the Editor-in-Chief
Taking Aim at Cancer
Therapeutic antibodies carry ‘payloads’ to destroy cancer cells.
by William G. Nelson, MD, PhD
-
Forward Look
Treating Brain Metastases
Neurologist David Schiff discusses the significance of new evidence-based guidance on how to treat brain metastases from solid tumors.
by Kendall K. Morgan
-
Forward Look
Many Online Pharmacies Are Illegitimate
Patients looking for online discounts for drugs should proceed with caution.
by Eric Fitzsimmons
-
Mysterious Microbes
Scientists look to decode the role of intestinal bacteria in our responses to immunotherapy.
by Natalie Slivinski
-
Capivasertib Extends Progression-Free Survival in Hormone Receptor-Positive Breast Cancer
The new AKT inhibitor doubled progression-free survival when added to treatment with Faslodex.
by Eric Fitzsimmons
-
Pregnancy After a Breast Cancer Diagnosis
Study finds pausing endocrine therapy is safe for early-stage breast cancer patients eager to expand their families.
by Thomas Celona
-
A ‘Revolution’ in Cancer Research
AACR patient advocate forum explores how new clinical trial designs are accelerating drug testing.
by Thomas Celona
-
Forward Look
A New Breast Cancer Subtype
Clinical trial results are changing care for people with metastatic breast cancer that expresses low levels of HER2 protein.
by Kris Conner
-
Chemo or Not?
Tumor profiling tests that predict the likelihood of distant recurrence can help some women with early-stage, hormone receptor-positive breast cancer decide on treatments after surgery.
by Kris Conner
-
Forward Look
Black Patients Less Likely to Receive Targeted Radiation
Study finds racial disparities in the use of proton beam therapy, a focused treatment that can reduce side effects.
by Carolyn Bernhardt
